Cleared Special

K030740 - MODIFICATION TO TINA-QUANT D-DIMER TEST SYSTEM

K030740 is an FDA 510(k) clearance for MODIFICATION TO TINA-QUANT D-DIMER TEST..., manufactured by Roche Diagnostics Corp.. The device is a Class 2 Hematology device with product code GHH cleared through the Special 510(k) pathway after a 22-day FDA review.

K030740 · Roche Diagnostics Corp. · Hematology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2003
Decision
22d
Days
Class 2
Risk

K030740 is an FDA 510(k) clearance for the MODIFICATION TO TINA-QUANT D-DIMER TEST SYSTEM. Classified as Fibrin Split Products (product code GHH), Class II - Special Controls.

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on April 1, 2003 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7320 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K030740

510(k) Number K030740 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 10, 2003
Decision Date April 01, 2003
Days to Decision 22 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d faster than avg
Panel avg: 113d · This submission: 22d
Pathway characteristics
Modification to existing cleared device.

GHH Device Classification - Class 2, Special Controls

Product Code GHH Fibrin Split Products
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GHH Fibrin Split Products

All 25
Devices cleared under the same product code (GHH) and FDA review panel - the closest regulatory comparables to K030740.
OLYMPUS D-DIMER REAGENT, MODEL OSR6X135, OLYMPUS D-DIMER CALIBRATOR, MODEL ODR3033, OLYMPUS D-DIMER CONTROL
K070453 · Olympus Life & Material Science Europa GmbH (Irish · Jun 2007
TINA-QUANT D-DIMER TEST SYSTEM
K062203 · Roche Diagnostics Corp. · Mar 2007
TRIAGE D-DIMER TEST, MODEL 98100
K042890 · Biosite Incorporated · Nov 2004
MDA D-DIMER
K021877 · bioMerieux, Inc. · Aug 2002
TINA-QUANT D-DIMER TEST SYSTEM
K011143 · Roche Diagnostics Corp. · May 2001
SIMPLIFY D-DIMER, MODEL DCGK1
K993276 · Agen Biomedical , Ltd. · Dec 1999
K030740 · MODIFICATION TO TINA-QUANT D-DIMER TEST SYSTEM
Download PDF FDA Summary Roche Diagnostics Cor…